NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has completed its $260 million acquisition of Fermentas International.
Fermentas sells reagents for nucleic acid and protein purification, restriction and modifying enzymes, molecular weight markers, and other life science research and diagnostic tools. It also offers various products for polymerase chain reaction, reverse transcription PCR, and quantitative PCR.
The firm will be integrated into Thermo Fisher's Analytical Technologies segment.
Based in Burlington, Ontario, with principal operations in Vilnius, Lithuania, Fermentas employs about 500. In 2009, it posted revenues of about C$57 million ($54 million).